Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, United Kingdom
Milrinone 1mg/ml Solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection/infusion. Clear, colourless to pale yellow solution, practically free from particles. The pH of the solution is 3.2-4.0 and the osmolality is 261–319 mOsm/Kg. |
Each 10 ml ampoule contains 10 mg milrinone. Each ml of solution contains 1 mg milrinone.
Excipient with known effect: Sodium (this medicinal product contains less than 1 mmol sodium (23 mg) per dose).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Milrinone |
Milrinone is a positive inotrope and vasodilator, with little chronotropic activity. It also improves left ventricular diastolic relaxation. It is a selective inhibitor of peak III phosphodiesterase isoenzyme in cardiac and vascular muscle. It produces slight enhancement of A-V node conduction, but no other significant electrophysiological effects. |
| List of Excipients |
|---|
|
(S)-Lactic acid |
Milrinone 1mg/ml Solution for Injection is presented in 10ml clear, neutral glass (PhEur, Type I) ampoules. The ampoules are packed in a PVC tray and cardboard box in packs of 10.
Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, United Kingdom
PL 29831/0619
01/08/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
